Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sincere CoTSE:7782 82 10-Year ROIIC % is 11.53 as of Dec. 2025. GuruFocus rates TSE:7782 with a GF Score™ of 82/100 and a GF Value™ of 円687.31 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 692 Medical Devices & Instruments companies, Sincere Co ranks better than 67.2% on this metric.
10-Year Return on Invested Incremental Capital (10-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 10-year.
Sincere Co's 10-Year ROIIC % for the quarter that ended in Dec. 2025 was 11.53%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Sincere Co's 10-Year ROIIC % or its related term are showing as below:
TSE:7782's 10-Year ROIIC % is ranked better than 67.2% of 692
companies
in the Medical Devices & Instruments industry
Industry Median: 2.3
vs TSE:7782: 11.53
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Sincere Co 10-Year ROIIC % Related Terms
Sincere Co 10-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Sincere Co's 10-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:7782 vs ISRG, BDX, MDLN: 10-Year ROIIC % Comparison
For the Medical Instruments & Supplies subindustry, Sincere Co's 10-Year ROIIC %, along with its competitors' market caps and 10-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sincere Co 10-Year ROIIC % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sincere Co's 10-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Sincere Co's 10-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 10-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Sincere Co (TSE:7782) has a 10-Year ROIIC % of 11.53 as of Dec. 2025. 10-Year ROIIC % measures the change in earnings as a percentage of change in investment over 10-year. View historical data on Sincere Co and its competitors. According to the industry distribution chart, Sincere Co ranks #227 out of 692 companies in the Medical Devices & Instruments industry, placing it in the top 32.8%.
Is Sincere Co's 10-Year ROIIC % too high?
Sincere Co's current 10-Year ROIIC % is 11.53. The Medical Devices & Instruments industry median 10-Year ROIIC % is 2.30. Sincere Co's value of 11.53 is 401.3% above this industry median. Based on the distribution chart, Sincere Co ranks #227 out of 692 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Sincere Co has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sincere Co's 10-Year ROIIC % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Sincere Co ranks #227 out of 692 companies for 10-Year ROIIC %. This puts Sincere Co in the upper half of its industry. The industry median 10-Year ROIIC % is 2.30. Sincere Co's value of 11.53 is 401.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 10-Year ROIIC % for a Medical Devices & Instruments company?
The median 10-Year ROIIC % among Medical Devices & Instruments companies is 2.30, based on 692 companies in the industry. Companies in the top quartile (top 25%) have a 10-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 10-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sincere Co's current 10-Year ROIIC % of 11.53 is 401.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 10-Year ROIIC % mean?
A high 10-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 10-Year ROIIC % measures the change in earnings as a percentage of change in investment over 10-year. View historical data on Sincere Co and its competitors. For the Medical Devices & Instruments industry, the median 10-Year ROIIC % is 2.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sincere Co's current 10-Year ROIIC % is 11.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sincere Co stock overvalued right now?
Based on GuruFocus' analysis, Sincere Co (TSE:7782) is currently considered Significantly Undervalued. The stock's GF Value™ is 円687.31, compared to a current price of 円468.00 — trading 31.9% below its estimated fair value. The current 10-Year ROIIC % is 11.53 and 401.3% above the Medical Devices & Instruments industry median of 2.30. Sincere Co's overall GF Score™ is 82/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 10-Year ROIIC % calculated?
10-Year ROIIC % is calculated from a company's financial statements. For Sincere Co (TSE:7782), the current 10-Year ROIIC % is 11.53 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sincere Co (TSE:7782) Overvalued in 2026?
Based on GuruFocus' analysis, Sincere Co stock appears to be undervalued.
The current stock price of 円468.00 is trading 31.9% below its estimated GF Value™ of 円687.31.
GuruFocus considers Sincere Co to be Significantly Undervalued.
Key valuation signals for TSE:7782:
10-Year ROIIC %: 11.53
GF Value™: 円687.31 vs. price of 円468.00 (31.9% below fair value)
Industry Position: 401.3% above the Medical Devices & Instruments median (#227 of 692)
No single metric tells the full story. See the TSE:7782 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sincere Co Ltd is a Japanese firm engaged in the manufacturing and sale of contact lens.As a company that manufactures and sells contact lenses, which are high-regulated medical devices, it place the highest priority on product safety and quality control, while working closely with company's customers to develop a variety-of-products and sell them at affordable prices to please as many customers as possible. The company opperates domestically as well as internationally.
82GF Score
Get the complete analysis for TSE:7782
10-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7782 has been successfully added to your 
